0
Please log in or register to do it.

Celltrion

Celltrion

▲ Celltrion[068270]It will participate in the ‘2024 European Crohn’s Disease and Colitis Conference’ (ECCO) held in Stockholm, Sweden from the 21st to the 24th (local time). At this conference, Celltrion will release a poster on the long-term efficacy and safety results of the global phase 3 clinical trial of ‘Remsima SC’ (ingredient name: infliximab), an autoimmune disease treatment drug conducted on patients with ulcerative colitis and Crohn’s disease, respectively. On the 22nd, a symposium will be held under the theme of ‘Achieving endoscopic treatment of infliximab subcutaneous injection formulation for inflammatory bowel disease: a journey toward improving long-term treatment results.’ (Seoul = Larose.VIP)

Report to KakaoTalk okjebo 2024/02/21 09:21 Sent

‘Aficionado’ Sung Si-kyung launches liquor brand ‘Kyung’ for the first time… Makgeolli launched
“The effects of exercise are greater for women than for men.”

Reactions

0
0
0
0
0
0
Already reacted for this post.

Reactions

Your email address will not be published. Required fields are marked *